keyword
https://read.qxmd.com/read/38623375/isotretinoin-unresponsive-acne-as-a-sign-of-a-congenital-disorder-a-case-of-21-hydroxylase-deficiency
#1
JOURNAL ARTICLE
Elisa Marzola, Vincenzo Bettoli
Acne is a multifactorial and common disorder among young people and a frequent reason for dermatology consultation. When moderate-to-severe acne is not responsive to conventional treatments, oral isotretinoin is a very effective solution. However, there are cases in which this treatment fails to produce the expected results. In this case, an 18-year-old male patient with acne, unresponsive to traditional acne therapies, experienced only a partial benefit from oral isotretinoin. Endocrinology consultation and hormonal work-up revealed androgen metabolism anomalies suggestive of a non-classical form of congenital adrenal hyperplasia due to 21-hydroxylase deficiency...
March 12, 2024: Dermatology Reports
https://read.qxmd.com/read/38576696/comparing-the-efficacy-of-topical-4-benzoyl-peroxide-versus-topical-0-1-adapalene-for-treatment-of-acne-vulgaris-in-skin-of-color-population-a-south-asian-perspective
#2
JOURNAL ARTICLE
Asmat Ullah, Anjum Muhammad, Farman Mehmood, Hina Farooq, Bilal Ahmad, Afnan Bin Haq, Naseem Khan, Syeda Naz, Asghar Khan, Afshan Saeed
Introduction Acne vulgaris is one of the most common skin problems encountered in the dermatology department. It is a chronic, inflammatory disease of the pilosebaceous unit, clinically presenting with comedones, papules, pustules, nodules, and cysts. With its particularly high prevalence in the younger population, it has significant adverse sequelae on patient's quality of life. At present, due to an enhanced understanding of the pathogenesis of acne, various therapeutic modalities are available. The current management strategies generally follow a systematic treatment escalation based on disease severity and treatment response...
March 2024: Curēus
https://read.qxmd.com/read/38564383/mitogen-activated-protein-kinase-inhibitor-induced-inflammatory-alopecia-in-woman-with-ovarian-cancer
#3
JOURNAL ARTICLE
Lucy Rose, Abena Minta, Jose Plaza, David E Cohn, Brittany Dulmage
Inflammatory alopecia is an increasingly reported side effect of targeted cancer therapies. Here we report one case of inflammatory alopecia secondary to mitogen-activated protein kinase kinase (MEK) inhibitor agent Trametinib in a woman with ovarian cancer. Biopsies of the scalp were consistent with early scarring alopecia compatible with drug-induced alopecia. Significant improvement in hair loss occurred after treatment with intralesional Kenalog (ILK) injections and oral isotretinoin. Though acute alopecia has been described in patients using MEK inhibitors, this is the first reported case of inflammatory alopecia...
April 1, 2024: Journal of Drugs in Dermatology: JDD
https://read.qxmd.com/read/38546101/oral-isotretinoin-with-desloratadine-compared-with-oral-isotretinoin-alone-in-the-treatment-of-moderate-to-severe-acne-a-randomized-assessor-blinded-study
#4
JOURNAL ARTICLE
Neirita Hazarika, Piyush Yadav, Manmohan Bagri, Divya Chandrasekaran, Riti Bhatia
BACKGROUND: Our aim was to measure the effectiveness of oral isotretinoin with desloratadine compared with oral isotretinoin alone in treating moderate to severe acne at a tertiary care teaching hospital in North India. In this study, 90 patients with moderate to severe acne were enrolled to participate based on their fulfilling the inclusion criteria. METHODS: A randomized, assessor-blinded, parallel-arm study was conducted. Randomization was done using computer-generated tables to allocate treatments in a 1:1 ratio...
March 28, 2024: International Journal of Dermatology
https://read.qxmd.com/read/38440005/retinoids-for-the-treatment-of-refractory-grover-s-disease-a-case-series-and-review-of-the-literature
#5
David Moodie, Charles Dunn, Chloe Fernandez, Rajiv Nathoo
Grover's disease, also known as transient acantholytic dermatosis (TAD), currently has no published randomized control trials regarding the treatment of the disease; thus, evidence for treatment is largely derived from case studies and case reports. In this case series, we summarize the current treatment options for Grover's disease and discuss two cases of refractory Grover's disease treated with low-dose oral isotretinoin in patients who previously failed to reach clearance with multiple treatment options...
February 2024: Curēus
https://read.qxmd.com/read/38433314/a-review-of-isotretinoin-in-the-treatment-of-frontal-fibrosing-alopecia
#6
REVIEW
Amirhossein Shahpar, Nazanin Zeinali Nezhad, Akram-Sadat Sahaf, Najmeh Ahramiyanpour
INTRODUCTION: Frontal fibrosing alopecia (FFA) is characterized by scarring alopecia of the frontotemporal scalp and facial papules. Isotretinoin is a vitamin A-derived retinoid discovered in 1955 and approved for treating nodulocystic acne. This drug can also affect facial papules and frontotemporal hair loss in patients with FFA. In this article, we conducted a review of the available studies investigating the use of oral isotretinoin for FFA treatment. Our study provides insights into the efficacy and safety of isotretinoin as a potential treatment option for FFA and highlights areas for future research...
March 3, 2024: Journal of Cosmetic Dermatology
https://read.qxmd.com/read/38388743/prevalence-of-acne-and-its-impact-on-quality-of-life-and-practices-regarding-self-treatment-among-medical-students
#7
JOURNAL ARTICLE
Duaa Dabash, Haya Salahat, Sally Awawdeh, Fadi Hamadani, Husam Khraim, Amer A Koni, Sa'ed H Zyoud
Acne vulgaris is one of the most common skin diseases worldwide and causes great distress to patients. In addition, most acne patients suffer from low self-esteem and social withdrawal. This study aimed to assess the prevalence of acne and its impact on quality of life among medical students. It also evaluates the patterns of self-treatment use. The study population consisted of all medical students from An-Najah National University (ANU) and the hospital. The questionnaire consists of three parts, and the first part consists of questions regarding demographic information...
February 22, 2024: Scientific Reports
https://read.qxmd.com/read/38313571/eczema-like-psoriasiform-dermatitis-due-to-hair-straighteners-trichoscopic-findings-and-clinical-experience-in-its-management
#8
JOURNAL ARTICLE
Yonatan Armendariz-Barragan, Daniel Jimenez-Zaragoza, Luis Enrique Sánchez-Dueñas
INTRODUCTION: Eczema-like psoriasiform dermatitis has been described as a complication after Brazilian keratin treatment, with the presence of perifollicular scale resembling the outer skin of an onion bulb reported as a characteristic trichoscopic feature. To date, no treatment for this condition has been communicated. METHODS: A retrospective study was conducted on patients diagnosed with eczema-like psoriasiform dermatitis. Clinical and trichoscopic images were analyzed, and the improvement in the scale and the vascular component of patients treated with oral isotretinoin was described...
February 2024: Skin Appendage Disorders
https://read.qxmd.com/read/38313565/use-of-oral-supplements-and-topical-adjuvants-for-isotretinoin-associated-side-effects-a-narrative-review
#9
REVIEW
Sophia Reyes-Hadsall, Teresa Ju, Jonette E Keri
Acne is a chronic inflammatory disease of the pilosebaceous unit with a multifactorial etiology and is one of the most common conditions treated by dermatologists and primary care physicians. Within an extensive and evolving treatment landscape, oral isotretinoin has demonstrated efficacy for treatment of severe, recalcitrant acne. Several side effects of isotretinoin have been reported, including laboratory abnormalities, mucocutaneous, and musculoskeletal effects, which may reduce compliance and patient satisfaction with treatment...
February 2024: Skin Appendage Disorders
https://read.qxmd.com/read/38306143/perceptions-utilization-and-cost-assessment-of-sebaceous-hyperplasia-treatment-modalities-a-pilot-survey
#10
JOURNAL ARTICLE
S H Millan, G E Sellyn, Adam J Friedman
BACKGROUND: Sebaceous hyperplasia (SH) is a common, benign but cosmetically bothersome skin condition preferentially affecting older adults. Despite multiple treatment options, there is no universally accepted first-line treatment for SH nor standard pricing for said approaches.  Methods: A survey aimed at evaluating treatment approaches and their respective costs was disseminated on the Orlando Dermatology Aesthetic and Clinical Conference email listserv.  Results: Out of 224 dermatologists who participated in the survey (response rate 9...
February 1, 2024: Journal of Drugs in Dermatology: JDD
https://read.qxmd.com/read/38300170/guidelines-of-care-for-the-management-of-acne-vulgaris
#11
JOURNAL ARTICLE
Rachel V Reynolds, Howa Yeung, Carol E Cheng, Fran Cook-Bolden, Seemal R Desai, Kelly Druby, Esther E Freeman, Jonette E Keri, Linda F Stein Gold, Jerry K L Tan, Megha M Tollefson, Jonathan S Weiss, Peggy A Wu, Andrea L Zaenglein, Jung Min Han, John S Barbieri
BACKGROUND: Acne vulgaris commonly affects adults, adolescents, and preadolescents aged 9 years or older. OBJECTIVE: The objective of this study was to provide evidence-based recommendations for the management of acne. METHODS: A work group conducted a systematic review and applied the Grading of Recommendations, Assessment, Development, and Evaluation approach for assessing the certainty of evidence and formulating and grading recommendations...
January 30, 2024: Journal of the American Academy of Dermatology
https://read.qxmd.com/read/38294764/drugs-for-acne
#12
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
February 5, 2024: Medical Letter on Drugs and Therapeutics
https://read.qxmd.com/read/38269210/isotretinoin-induced-dyslipidemia-a-single-center-study-in-saudi-arabia
#13
JOURNAL ARTICLE
Mahdi Al Dhafiri, Feroze Kaliyadan, Sara Almukhaimar, Fatemah Abdulrahman Alsultan, Elham Al Hayim, Roaa Alnaim, Alaa Aldossari
PURPOSE: Acne is a chronic inflammatory skin disease with a high prevalence in Saudi Arabia. Isotretinoin is used to treat severe, resistant nodulocystic acne. Side effects include joint discomfort, headache, mucosal dryness, and nose bleeds. Elevated lipids and liver enzymes have also been recorded. The study goal is to identify the prevalence of increased lipid levels during and after isotretinoin use. PATIENTS AND METHODS: This retrospective study was conducted in the dermatology polyclinic at King Faisal University, Al-Ahsa, Saudi Arabia...
2024: Patient Preference and Adherence
https://read.qxmd.com/read/38245761/the-impact-of-oral-isotretinoin-on-ovarian-functions-of-acne-patients-complaining-of-polycystic-ovarian-syndrome-a-prospective-study
#14
JOURNAL ARTICLE
Heba I Elnagar, Osama A Hashem, Hany O Aboelwafa, Ehab Elhelw, Mohamed L Elsaie
BACKGROUND: Women have polycystic ovarian syndrome (PCOS) at higher rates than any other endocrine condition with an average incidence rate of 6 to 8%. Acne is an immune mediate common condition frequently affecting adolescents and adults and is often associated with PCOS. The objective of the study was to assess the impact of oral isotretinoin on ovarian functions of acne patients suffering from PCOS. Forty women with a clinical diagnosis of acne as well as PCOS participated in this prospective clinical trial...
January 20, 2024: Journal of Ovarian Research
https://read.qxmd.com/read/38243868/treatment-of-ocular-rosacea-a-systematic-review
#15
REVIEW
Shani Avraham, Sophie Khaslavsky, Nadia Kashetsky, Samantha Y Starkey, Kirill Zaslavsky, Joseph M Lam, Ilya Mukovozov
Rosacea is a common chronic skin disease distributed primarily around the central face. Ocular manifestations of rosacea are poorly studied, and estimates of prevalence vary widely, ranging from 6% to 72% in the rosacea population. Treatment options for ocular rosacea include lid hygiene, topical and oral antibiotics, cyclosporine ophthalmic emulsion, oral vitamin A derivatives, and intense pulsed light; however, a direct comparison of treatment methods for ocular rosacea is lacking. This review aims to compare treatment efficacy and adverse events for different treatment modalities in ocular rosacea...
January 20, 2024: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/38227885/network-analysis-finds-oral-isotretinoin-most-effective-for-acne-vulgaris
#16
JOURNAL ARTICLE
Henry C Barry
No abstract text is available yet for this article.
January 2024: American Family Physician
https://read.qxmd.com/read/38183614/the-microbiome-and-acne-perspectives-for-treatment
#17
REVIEW
Clio Dessinioti, Andreas Katsambas
The skin microbiome consists of the microorganisms populating the human skin. Cutibacterium acnes (C. acnes, formerly named Propionibacterium acnes) is recognized as a key factor in acne development, regulating inflammatory and immune pathways. Dysbiosis has been described as the imbalance in skin microbiome homeostasis and may play a role in acne pathogenesis. Microbial interference has been shown to be a contributor to healthy skin homeostasis and staphylococcal strains may exclude acne-associated C...
January 6, 2024: Dermatology and Therapy
https://read.qxmd.com/read/38169356/-top-4-research-studies-of-the-month-for-italian-primary-care-physicians-december-2023
#18
JOURNAL ARTICLE
Peter K Kurotschka, Alice Serafini, Mark H Ebell
This monthly article provides a collection of summaries of the most relevant studies identified as POEMs (patient-oriented evidence that matters) for Italian primary care physicians. 1) According to a high-quality network meta-analysis, oral isotretinoin is the most effective therapy for decreasing the number of inflammatory and non-inflammatory skin lesions in patients with acne vulgaris. 2) Non-steroidal anti-inflammatory drug (Nsaid) use is associated with a small increase (0.004%) in the risk of venous thromboembolism...
January 2024: Recenti Progressi in Medicina
https://read.qxmd.com/read/38161524/isotretinoin-use-and-liver-enzymes-changes-a-single-center-study-in-saudi-arabia
#19
JOURNAL ARTICLE
Mahdi Al Dhafiri, Feroze Kaliyadan, Sara Almukhaimar, Fatemah Alsultan, Elham Al Hayim, Roaa Alnaim, Alaa Aldossari
Introduction Isotretinoin is a bioactive retinoic acid variant that is taken orally to treat moderate to severe acne vulgaris. One of the adverse effects of isotretinoin is elevated liver enzymes. This study estimated the prevalence of liver enzyme changes during isotretinoin use among dermatology clinic patients in Al-Ahsa, Kingdom of Saudi Arabia. Methods This study was a retrospective analysis that reviewed the medical data of 97 patients with acne at the King Faisal University Polyclinic who were taking systemic isotretinoin...
December 2023: Curēus
https://read.qxmd.com/read/38154809/managing-acne-vulgaris-an-update
#20
REVIEW
Miriam Santer, Esther Burden-Teh, Jane Ravenscroft
Acne vulgaris is very common and can have significant negative impact on people. While sometimes a transient problem, acne may persist for many years and often leads to permanent scars or pigment changes. Guidelines unanimously advise topical treatments as first-line, although differ in recommending either topical benzoyl peroxide or topical retinoid (mainly adapalene) alone or in combination. Guidance published by the National Institute for Health and Care Excellence advises counselling patients regarding avoidance of skin irritation when starting topical treatments and promoting adherence (treatments take 6-8 weeks to work)...
December 27, 2023: Drug and Therapeutics Bulletin
keyword
keyword
118575
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.